TB Alliance: Difference between revisions

'''The Global Alliance for TB Drug Development''' ''('''''TB Alliance''') is a not-for-profit product development partnership dedicated to the discovery and development of new, faster-acting and affordable [[tuberculosis]] medicines. Since its inception in 2000, TB Alliance has worked to grow the field of available treatments for TB and now manages the largest [[Drug pipeline|pipeline]] of new TB drugs in history.<ref>{{Cite web|url=https://www.tballiance.org/portfolio|title=Clinical Portfolio {{!}} TB Alliance|website=www.tballiance.org|language=en|access-date=2017-06-20}}</ref> It was founded in [[Cape Town]], South Africa, and has since expanded. It is headquartered in [[New York City]] and has a regional officesoffice in [[Brussels]] and [[Pretoria]].<ref>{{Cite web|url=http://www.tballiance.org/annualreport2016/|title=Home {{!}} TB Alliance 2016 Annual Report|website=TB Alliance 2016 Annual Report|language=en-US|access-date=2017-06-20}}</ref>